ReShape Lifesciences Files 8-K on Security Holder Rights
Ticker: HIND · Form: 8-K · Filed: May 9, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, amendment, filing
TL;DR
ReShape Lifesciences filed an 8-K on May 6, 2025, for changes to security holder rights and company bylaws.
AI Summary
On May 6, 2025, ReShape Lifesciences Inc. filed an 8-K report detailing material modifications to security holder rights and amendments to its articles of incorporation. The company, formerly known as Obalon Therapeutics Inc., is based in San Clemente, California, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates potential changes affecting the rights of ReShape Lifesciences' security holders and amendments to the company's foundational documents, which could impact investors.
Risk Assessment
Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate documents can introduce uncertainty and potential shifts in corporate governance or financial structure.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- Obalon Therapeutics Inc. (company) — Former company name
- May 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Irvine, CA (location) — Principal executive offices
FAQ
What specific modifications were made to the rights of ReShape Lifesciences' security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text.
What amendments were made to ReShape Lifesciences' articles of incorporation or bylaws?
The filing states there were amendments to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 6, 2025.
What was ReShape Lifesciences Inc. formerly known as?
ReShape Lifesciences Inc. was formerly known as Obalon Therapeutics Inc.
In which state was ReShape Lifesciences Inc. incorporated?
ReShape Lifesciences Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding ReShape Lifesciences Inc. (HIND).